Page last updated: 2024-08-25

acamprosate and Brain Ischemia

acamprosate has been researched along with Brain Ischemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bähr, M; Doeppner, TR; Hermann, DM; Kaltwasser, B; Kilic, E; Pehlke, JR; Schlechter, J1
Engelhard, K; Kochs, E; Lu, H; Möllenberg, O; Werner, C; Zieglgänsberger, W1

Other Studies

2 other study(ies) available for acamprosate and Brain Ischemia

ArticleYear
The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained neuroprotection and neuroregeneration.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015, Volume: 35, Issue:12

    Topics: Acamprosate; Animals; Blood-Brain Barrier; Brain Ischemia; Calpain; Enzyme Activation; Interleukin-12 Subunit p35; JNK Mitogen-Activated Protein Kinases; Male; Mice; Neovascularization, Physiologic; Nerve Regeneration; Neuroprotective Agents; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Recovery of Function; STAT6 Transcription Factor; Taurine

2015
[The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e].
    Der Anaesthesist, 2000, Volume: 49, Issue:9

    Topics: Acamprosate; Alcohol Deterrents; Anesthetics, Intravenous; Animals; Brain Ischemia; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fentanyl; Lipid Peroxidation; Male; Neuroprotective Agents; Peroxidase; Pyrimidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Taurine

2000